Enhabit CFO Solomon Ryan Buys 10,000 Shares at $7.64/Share.
ByAinvest
Monday, Aug 11, 2025 6:36 pm ET1min read
EHAB--
The company’s hospice revenue grew significantly, up 19.4% year-over-year, driven by strategic investments in technology and operational improvements. Key takeaways include strong performance in the hospice segment, effective cost management strategies, and a focus on operational efficiency and debt reduction [1].
Financial highlights for the quarter include revenue of $266.1 million, up 2.1% year-over-year, and adjusted EBITDA of $26.9 million, a 6.7% increase year-over-year. The company’s stock price increased by 15.07% post-earnings, reflecting strong investor confidence [1].
The company projects revenue between $1.060 billion and $1.073 billion for the full year, with adjusted EBITDA guidance set at $104 million to $108 million. CEO Barb Jacobsmeyer emphasized the company’s strategic investments, while CFO Ryan Solomon highlighted concerns about proposed rate cuts [1].
Enhabit Inc. continues to face challenges, including CMS reimbursement pressures and the upcoming CEO transition in 2026. The company is actively working to mitigate these risks and maintain access to high-quality care [1].
Additionally, it was announced that CFO Ryan Solomon acquired 10,000 shares of Enhabit Inc. at a price of $7.64 per share on August 8, 2025. This transaction reflects the CFO’s confidence in the company’s future prospects [2].
References:
[1] https://www.investing.com/news/transcripts/earnings-call-transcript-enhabit-inc-q2-2025-earnings-beat-boosts-stock-15-93CH-4178050
[2] [Source for CFO share acquisition]
Enhabit, Inc. (EHAB) has announced that Solomon Ryan, the company's Chief Financial Officer, has acquired 10,000 shares at a price of $7.64 per share on August 8, 2025.
Enhabit Inc. (EHAB) has reported better-than-expected earnings for the second quarter of 2025, with earnings per share (EPS) reaching $0.13, surpassing analysts’ forecast of $0.10 by 30%. Revenue also exceeded expectations, coming in at $266.1 million against a forecast of $263.39 million. The company’s stock responded positively, surging 15.07% to $7.15 following the announcement [1].The company’s hospice revenue grew significantly, up 19.4% year-over-year, driven by strategic investments in technology and operational improvements. Key takeaways include strong performance in the hospice segment, effective cost management strategies, and a focus on operational efficiency and debt reduction [1].
Financial highlights for the quarter include revenue of $266.1 million, up 2.1% year-over-year, and adjusted EBITDA of $26.9 million, a 6.7% increase year-over-year. The company’s stock price increased by 15.07% post-earnings, reflecting strong investor confidence [1].
The company projects revenue between $1.060 billion and $1.073 billion for the full year, with adjusted EBITDA guidance set at $104 million to $108 million. CEO Barb Jacobsmeyer emphasized the company’s strategic investments, while CFO Ryan Solomon highlighted concerns about proposed rate cuts [1].
Enhabit Inc. continues to face challenges, including CMS reimbursement pressures and the upcoming CEO transition in 2026. The company is actively working to mitigate these risks and maintain access to high-quality care [1].
Additionally, it was announced that CFO Ryan Solomon acquired 10,000 shares of Enhabit Inc. at a price of $7.64 per share on August 8, 2025. This transaction reflects the CFO’s confidence in the company’s future prospects [2].
References:
[1] https://www.investing.com/news/transcripts/earnings-call-transcript-enhabit-inc-q2-2025-earnings-beat-boosts-stock-15-93CH-4178050
[2] [Source for CFO share acquisition]

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet